查詢結果分析
來源資料
相關文獻
- 幽門螺旋桿菌抗藥性之機轉及盛行率
- One-Week Proton Pump Inhibitor-Based Triple Therapy Eradicates Residual Helicobacter Pylori after Failed Dual Therapy
- 幽門螺旋桿菌藥物治療的現況
- 益生菌降低幽門螺旋桿菌之療效
- 根除幽門螺旋桿菌之病例用藥探討
- Development of Multifocal Duodenal Erosions after Anti-Helicobacter Pylori Triple Therapy
- 幽門螺旋桿菌除菌治療新趨勢
- 漫談幽門螺旋桿菌感染及基層醫療之對策
- One-Week Low-Dose Triple Therapy is Effective in Treating Helicobacter Pylori-Infected Patients with Bleeding Peptic Ulcers
- New One-Week, Low-Dose Triple Therapy for the Treatment of Duodenal Ulcer with Helicobacter Pylori Infection
頁籤選單縮合
題 名 | 幽門螺旋桿菌抗藥性之機轉及盛行率=Prevalence and Mechanism of Antibiotics Resistance of Helicobacter Pylori |
---|---|
作 者 | 劉鐘軒; 陳啟清; 張煥禎; 郭佑啟; | 書刊名 | 中華民國重症醫學雜誌 |
卷 期 | 11:2 2010.08[民99.08] |
頁 次 | 頁115-119 |
分類號 | 415.526 |
關鍵詞 | 幽門螺旋桿菌; 三合一療法; 氫質幫浦抑制劑; Helicobacter pylori; Triple therapy; Proton pump inhibitor; Clarithromycin; Metronidazole; Amoxicillin; |
語 文 | 中文(Chinese) |
英文摘要 | Helicobacter pylori is a common pathogen of the gastric mucosa, the prevalence of Helicobacter pylori infection world-wide is approximately 50%. Seven-day triple therapy eradication regimens, based on a proton pump inhibitor or bismuth salts in combination with two antibiotics, are the currently recommended treatments for H. pylori infection. However, treatment failure is often associated with resistance to these antibiotics. Understanding the mechanism of antibiotic resistance and prevalence of resistance will allow clinicians to choose suitable therapy. |
本系統中英文摘要資訊取自各篇刊載內容。